5g of This Focus Drug Beats Any Nootropic In 2026
Dave Asprey — appearances & channel — 5g of This Focus Drug Beats Any Nootropic In 2026
Channel: Dave Asprey · Our label: Biohacking entrepreneur (Bulletproof founder) · Source: youtube.com/watch?v=TtK75OtRp7o
What this video covers
picture a molecule so unusual scientists had [music] to invent a new word for it. Something that was invented back in the ’60s, but [music] no one knew about it. This molecule got me through my career in Silicon Valley and through Wharton Business School, even though no one else was using it. 60 years later, people still take it, including me, for memory, for focus, for creativity, and for mental endurance.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- Who benefits versus who probably doesn’t benefit, how to stack them if you’re going to do it yourself, and regulatory reality and sourcing risk because not everything is as it seems.
- But it’s funny how things can be true even without studies because we have this other form of evidence called observational or clinical evidence.
- We understand mechanistically how they work, but clinical studies can add some interesting data.
- They accumulate, then they send out inflammatory signals and they disrupt your natural hair growth cycle.
- The fact that there isn’t any good safety data on something doesn’t mean it’s dangerous, but it doesn’t mean it’s safe either.
- Uh there’s no double blind clinical trial showing that jumping out of a airplane without a parachute is dangerous.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.